TERT promoter mutations are known to be molecular markers of an aggressive phenotype, with which even LGGs behave like GBMs, and the pathological diagnosis of such cases is GBM-IDHwt, according to the 2021 WHO classification of tumors of the CNS10. This evidence concerns the gene TERT and glioblastoma.